Holen Sie sich die Stockscreener-App
42.95
7.03%
2.82
Handel nachbörslich:
42.80
-0.15
-0.35%
Schlusskurs vom Vortag:
$40.13
Offen:
$40.46
24-Stunden-Volumen:
4.87M
Relative Volume:
3.41
Marktkapitalisierung:
$3.08B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-368.95M
KGV:
-7.7453
EPS:
-5.5453
Netto-Cashflow:
$-293.81M
1W Leistung:
+0.09%
1M Leistung:
+33.01%
6M Leistung:
-11.77%
1J Leistung:
+86.98%
1-Tages-Spanne:
$40.00
$44.60
1-Wochen-Bereich:
$36.76
$44.60
52-Wochen-Spanne:
$19.07
$56.05
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
42.95 | 2.88B | 0 | -368.95M | -293.81M | -5.5453 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.93 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.50 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-10-16 | Eingeleitet | BofA Securities | Buy |
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Why Is Vera Therapeutics Stock Gaining Tuesday? - Benzinga
VERA Stock Holds Gains As CEO Trims Stake In Form 4 Sale - StocksToTrade
Vera Therapeutics gains FDA nod for TRUTAKNA launch - TipRanks
US FDA approves Vera's kidney disease drug - Reuters
Vera gains after FDA nod for kidney disease therapy - Seeking Alpha
FDA grants accelerated approval to Vera Therapeutics (NASDAQ: VERA) drug TRUTAKNA - Stock Titan
Vera Therapeutics Receives FDA Accelerated Approval for - GlobeNewswire
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy - Yahoo Finance
VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - Stocktwits
'I got back to living my normal life': How Vera Therapeutics' drug renewed a kidney patient ahead of FDA test - The Business Journals
What's Going on with Vera Therapeutics Stock on Monday? - Benzinga
Vera Therapeutics Shares Climb Ahead of FDA Decision on Atacicept (VERA) - Yahoo Finance
Scilex, Vera Therapeutics rise premarket; Strategy gains By Investing.com - Investing.com Canada
Vera Therapeutics stock rises ahead of FDA decision By Investing.com - Investing.com Canada
VERAVera Therapeutics Inc Short Interest - Finviz
Is Vera Therapeutics, Inc. (VERA) A Good Stock To Buy Now? - Yahoo Finance
Vera Therapeutics updates kidney disease pipeline as investors weigh long-term potential - AD HOC NEWS
FDA Progress Could Send This Biotech Stock Soaring To New Heights - Yahoo Finance
Vera Therapeutics (VERA) Declines as Biotech Sector Faces HeadwindsJelly Roll Trade - dars.gov.et
7 FDA decisions to watch for in Q3 - BioSpace
$Vera Therapeutics (VERA.US)$ - Moomoo
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $56 to $90 - Moomoo
VERA Forecast — Price Target — Prediction for 2027 - TradingView
Vera Therapeutics, Inc. Class A Actuals & Estimates (NASDAQ:VERA) - TradingView
Vera Therapeutics Inc (VERA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Raymond James Maintains Vera Therapeutics(VERA.US) With Buy Rating - Moomoo
Form 4 Vera Therapeutics Inc For: 24 June By Investing.com - Investing.com Nigeria
Vera Therapeutics president and CEO Fordyce Marshall sells $701,769 in stock - Investing.com
Vera Therapeutics Insider Sold Shares Worth $701,769, According to a Recent SEC Filing - marketscreener.com
Vera Therapeutics (VERA) CEO sells 18,500 shares under 10b5-1 plan - Stock Titan
Form 144 Vera Therapeutics For: 23 June By Investing.com - Investing.com Australia
VERA (NASDAQ: VERA) plans resale of 74,000 shares via option exercise - Stock Titan
3 biotech firms with major potential catalysts in the coming months - MSN
3 Biotech Firms With Major Potential Catalysts in the Coming Months - MarketBeat
Vera Therapeutics (VERA) Is Up 10.7% After Accelerated FDA Timeline For Atacicept IgAN FilingHas The Bull Case Changed? - Sahm
Vera Therapeutics Inc (VERA) Institutional Confidence - TradingKey
(VERA) Risk Channels and Responsive Allocation - Stock Traders Daily
Vera Therapeutics Inc (VERA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vera Therapeutics Inc (VERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vera Therapeutics Inc (VERA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vera Therapeutics Inc (VERA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vera Therapeutics stock gains 4.13% as Official VeraTx promotes new IgANime accessory features - Traders Union
Vera Therapeutics Inc (VERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vera Therapeutics Inc (VERA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vera Therapeutics Inc (VERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vera Therapeutics (VERA) Appears Attractive After Latest FDA Agreement - Insider Monkey
Insiders At Vera Therapeutics Sold US$1.9m In Stock, Alluding To Potential Weakness - Moomoo
Vera Therapeutics (VERA) Receives a Buy from Wells Fargo - The Globe and Mail
Vera Therapeutics moves closer to full approval for kidney disease drug after FDA alignment - MSN
Will FDA Alignment on Atacicept’s eGFR Plan Reshape Vera Therapeutics’ (VERA) IgA Nephropathy Narrative - Yahoo Finance
CLDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):